Document is current
Any future updates will be listed below
-
Authors
Suzuki, Koji https://orcid.org/0000-0003-1358-7069
Akiyama, Mitsuhiro https://orcid.org/0000-0001-5075-8977
Fukui, Hiroyuki https://orcid.org/0009-0004-8401-8044
Kaneko, Yuko https://orcid.org/0000-0003-2646-5765
- License Information
-
More Information
Article History
Received: 17 October 2024
Accepted: 23 December 2024
First Online: 31 December 2024
Declarations
:
: Written informed consent for publication of this report was obtained from the patient.
: MA has received speaking fees from AbbVie, Asahi-Kasei, Astellas, Boehringer Ingelheim, Chugai, Eisai, Eli Lilly, Janssen, Novartis, Pfizer, Taisho, UCB, Gilead Sciences. YK has received research grants from AbbVie, Eisai, Sanofi, Chugai, Mitsubishi-Tanabe, Taisho, and has received scholarship grant from Asahi-Kasei, Eisai, Boehringer Ingelheim, Taisho, and has received speaking fees from AbbVie, Asahi-Kasei, Astellas, Ayumi Pharmaceutical Corporation, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai, Eisai, Eli Lilly, Glaxo Smith Kline, Janssen, Novartis, Pfizer, UCB, Gilead Sciences. KS and SF declare that they have no conflict of interest.
